Annual Meeting 2016: Subgrouping rarer cancers and clinical trial design

VJOncology has 409 videos Subscribe Here

Description: Bruce Johnson, MD, from Dana-Farber Cancer Institute, Boston, MA, explains the challenges associated with developing clinical trials for patients with rarer solid tumors, including defining subgroups of patients for specific therapeutic approaches and recruiting sufficient numbers of participants. Recorded at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO).
Shared By : VJOncology
Posted on : 06/10/16
Added : 1 year ago
Category : General


Nothing found.

More From VJOncology

Nothing found.